Cyclacel Pharmaceuticals, Inc. (CYCC) Reports Q3 Loss of $0.37
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) reported Q3 EPS of ($0.37), versus ($0.43) reported last year.
For earnings history and earnings-related data on Cyclacel Pharmaceuticals, Inc. (CYCC) click here.
For earnings history and earnings-related data on Cyclacel Pharmaceuticals, Inc. (CYCC) click here.